AI
“Alibaba has open-sourced an AI model capable of detecting cancer and nearly 150 other medical conditions from diagnostic data." (Instagram, @aigramapp, 2026-09-19, citing South China Morning Post via news.ycombinator.com)”
Plain restatementAlibaba has publicly released, under an open licence, an AI model that identifies cancers and approximately 150 additional medical conditions from diagnostic inputs.
Distortion code this site does not recognise yet: demo_to_product_conflation. Not collectible until the field guide has an entry.
This one mostly checks out. On 17 September 2026 Alibaba's DAMO Academy published a model called RADAR in the journal Science, and on 18 September it posted the code on GitHub and the model checkpoints on Hugging Face. The paper reports the model identifies 146 findings across 18 abdominal organs from contrast-enhanced CT scans, including liver, pancreas, stomach and colorectal cancers, and that it outperformed most of the 26 radiologists in a comparison study. Two details in the post are off. The cancers are counted inside the 146 findings, so it is not "cancer plus nearly 150 other conditions," and the model works on abdominal CT scans specifically, not on general "diagnostic data." Several outlets also report that while the code is fully open source, the model weights carry a licence that allows research use but bars commercial deployment, which is a real limit on the post's claim that the release democratizes access. The model is a research release and has not been shown to be cleared by any regulator for clinical use.
Alibaba has [drifted from the evidence:] open-sourced an AI model [drifted from the evidence:] capable of detecting cancer and [drifted from the evidence:] nearly 150 [drifted from the evidence:] other medical conditions from diagnostic [drifted from the evidence:] data." (Instagram, @aigramapp, 2026-09-19, citing South China Morning Post via news.ycombinator.com)
Alibaba has [added by the neutral restatement:] publicly released, under an [added by the neutral restatement:] open licence, an AI model [added by the neutral restatement:] that identifies cancers and [added by the neutral restatement:] approximately 150 [added by the neutral restatement:] additional medical conditions from diagnostic [added by the neutral restatement:] inputs.
Red-tinted words in the claim drifted from the evidence. Green-tinted words are what a neutral restatement needs.
The trace / claim to source
- Alibaba's research arm, DAMO Academy, did publicly release an AI model for medical diagnosis, with code on GitHub under Apache 2.0 and checkpoints on Hugging Face, on 18 September 2026.
- The model detects cancers. Pathology-confirmed evaluation covered liver, pancreas, stomach and colorectal cancers with AUCs of 0.891 to 0.984.
- The figure of roughly 150 conditions traces to a real number: 146 imaging findings across 18 anatomical structures.
- The underlying work is peer-reviewed and appeared in Science, not a preprint or a blog post.
- SCMP did report the story, so the post's cited chain is genuine.
- Exaggeration: the post says "cancer and nearly 150 OTHER medical conditions." The evidence says 146 findings in total, with cancers counted among them. The added word "other" converts a total into a total-plus-cancer and inflates the scope by the most attention-grabbing category.
- Omitted qualifier: the post says "from diagnostic data." The model reads contrast-enhanced abdominal CT scans only, covering 18 abdominal organs. A reader is left to imagine a general-purpose diagnostician working from any medical data, which the evidence does not support. This is the single largest gap between the post and the paper.
- Definitional dispute over "open-sourced": the code carries Apache 2.0, an OSI-approved licence, but the weights are reported by several outlets to carry CC BY-NC-SA 4.0, which forbids commercial use. If that holds, the release is open-weights-for-research rather than open source in the full sense, and the post's framing that it will "democratize access" to medical AI tools overstates what a hospital or startup could legally deploy. The remaining disagreement here is definitional, but the underlying licence facts are what matter.
- Demo to product conflation: "capable of detecting" reads as a deployable clinical capability. The evidence is retrospective cohort evaluation plus a reader study. Regulatory clearance and prospective outcome data are not established by this release.
- The exact licence on the Hugging Face weights. Three secondary outlets state CC BY-NC-SA 4.0, and one notes the GitHub LICENSE file says Apache 2.0 while a badge in the same README points to CC BY-NC-SA 4.0. I could not retrieve the Hugging Face licence field itself, so this is reported, not verified at the artifact.
- Whether the release includes full training weights for all variants (RADAR and RADAR+) or a subset. The repository references both, and I did not enumerate the checkpoint files.
- Independent reproduction of the reported performance. None exists yet; the release is two days old as of 2026-09-20.
- Regulatory status. No clearance for clinical use was found for this specific model. A separate earlier DAMO pancreatic-cancer model is referenced elsewhere as having US FDA Breakthrough Device designation, which is a different artifact and does not transfer to RADAR.
Alibaba DAMO Academy, with the First Affiliated Hospital of Zhejiang University School of Medicine and other clinical partners, published a model called RADAR (marketed as DAMO RADAR) in Science on 17-18 September 2026, and released code and model checkpoints publicly on GitHub and Hugging Face on 18 September 2026. The Science abstract states the model was evaluated across 18 anatomical structures and 146 imaging findings, reaching an AUC of 0.913 (95% CI 0.911 to 0.915) on a real-world internal cohort of 39,160 examinations, and AUCs of 0.874 to 0.912 across eight external centres. For pathology-confirmed evaluation of four cancer types (liver, pancreas, stomach, colorectum), AUCs were 0.891 to 0.984. On acute abdominal conditions excluded from initial training, AUC was 0.904. In a reader study with 26 radiologists from 14 centres, the paper reports the model outperformed most participants. The AAAS release states RADAR's mean AUC of 0.913 compares with 0.776 for existing specialist AI models. The GitHub README describes RADAR as a generalist vision-language model trained on over 400,000 contrast-enhanced abdominal CT examinations with 15 million anatomy-aware image-text pairs, learning from clinical reports without manual annotation, and states: "This project is released under the Apache License 2.0." Checkpoints and supporting files are hosted on Hugging Face. Multiple tech outlets report that the weights on Hugging Face carry a CC BY-NC-SA 4.0 licence, which permits research use but bars commercial deployment. I was not able to retrieve the Hugging Face licence field directly.
Complete reasoning
The reply is formatted for pasting into the thread where the claim is circulating.
Compact share page: ai.trueseeker.com/s/587d3fb6e6f2/O3ORE6QI52MRx2RpIu7QrpuNP6V
Ask this case
Answers come only from the case file above; nothing is added.
Did Alibaba actually release an AI model that can detect cancer?
Yes. DAMO Academy, Alibaba's research arm, published a model called RADAR in the journal Science and released its code on GitHub and checkpoints on Hugging Face on 18 September 2026. Pathology-confirmed testing showed it can identify liver, pancreas, stomach and colorectal cancers with AUCs of 0.891 to 0.984.
Does the model detect nearly 150 conditions in addition to cancer?
Not quite. The paper reports 146 findings in total across 18 abdominal organs, and cancers are counted as part of that 146, not added on top of it. The post's wording exaggerates the scope by treating cancer as separate from the count.
Can this model diagnose from any kind of medical data?
No. The evidence shows the model works specifically on contrast-enhanced abdominal CT scans, not general diagnostic data of any kind. This is described as the biggest gap between the post's claim and what the case file supports.
Is this really 'open source' in the full sense?
The code is released under Apache 2.0, an open source licence, but several outlets report the model weights on Hugging Face carry a CC BY-NC-SA 4.0 licence, which allows research use but blocks commercial deployment. The case file could not directly verify the Hugging Face licence field, so this detail is reported by secondary sources rather than confirmed at the source.
Is RADAR approved for use in hospitals?
The investigation did not establish any regulatory clearance for RADAR's clinical use. It is described as a research release backed by cohort evaluation and a reader study, not a product cleared by any regulator.